References
- Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. (2000). Immunobiology of dendritic cells. Annu Rev Immunol, 18, 767–811.
- Borges O, Borchard G, Verhoef JC, de Sousa A, Junginger HE. (2005). Preparation of coated nanoparticles for a new mucosal vaccine delivery system. Int J Pharm, 299, 155–166.
- Chen SC, Wu YC, Mi FL, Lin YH, Yu LC, Sung HW. (2004). A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery. J Control Release, 96, 285–300.
- Clark MA, Jepson MA, Simmons NL, Booth TA, Hirst BH. (1993). Differential expression of lectin-binding sites defines mouse intestinal M-cells. J Histochem Cytochem, 41, 1679–1687.
- Constant SL, Bottomly K. (1997). Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol, 15, 297–322.
- Cremer BK, Kreuter J.. (1996). Preparation and characterization of chitosan microsphere as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J Control Release, 39, 17–25.
- Dobakhti F, Rahimi F, Dehpour AR, Taghikhani M, Ajdary S, Rafiei S, Rafiee-Tehrani M. (2006). Stabilizing effects of calcium alginate microspheres on Mycobacterium bovis BCG intended for oral vaccination. J Microencapsul, 23, 844–854.
- George M, Abraham TE. (2006). Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan–a review. J Control Release, 114, 1–14.
- Goyal AK, Khatri K, Mishra N, Vyas SP. (2008). New patents on mucosal delivery of vaccines. Expert Opin Ther Patents, 18, 1–18.
- Gullberg E, Keita AV, Salim SY, Andersson M, Caldwell KD, Söderholm JD, Artursson P. (2006). Identification of cell adhesion molecules in the human follicle-associated epithelium that improve nanoparticle uptake into the Peyer’s patches. J Pharmacol Exp Ther, 319, 632–639.
- Gupta PN, Khatri K, Goyal AK, Mishra N, Vyas SP. (2007). M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B. J Drug Target, 15, 701–713.
- Hejazi R, Amiji M. (2002). Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan microspheres. Int J Pharm, 235, 87–94.
- Holmgren J, Czerkinsky C. (2005). Mucosal immunity and vaccines. Nat Med, 11, S45–S53.
- Jain AK, Goyal AK, Gupta PN, Khatri K, Mishra N, Mehta A, Mangal S, Vyas SP. (2009). Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B. J Control Release, 136, 161–169.
- Jain S, Singh P, Mishra V, Vyas SP. (2005). Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol Lett, 101, 41–49.
- Kim CK, Lee EJ. (1992). The controlled release of blue dextran from alginate beads. Int J Pharm, 79, 11–19.
- Liu X, Chen D, Xie L, Zhang R. (2003). Oral colonspecific drug delivery for bee venom peptide: development of a coated calcium alginate gel beads-entrapped liposome. J Control Release, 93, 293–300.
- van der Lubben IM, Kersten G, Fretz MM, Beuvery C, Coos Verhoef J, Junginger HE. (2003). Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. Vaccine, 21, 1400–1408.
- Malik B, Goyal AK, Mangal S, Zakir F, Vyas SP. (2010). Implication of gut immunology in the design of oral vaccines. Curr Mol Med, 10, 47–70.
- McKenzie BS, Brady JL, Lew AM. (2004). Mucosal immunity: overcoming the barrier for induction of proximal responses. Immunol Res, 30, 35–71.
- Mishra N, Tiwari S, Vaidya B, Agrawal GP, Vyas SP. (2011). Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B. J Drug Target, 19, 67–78.
- Montalbetti CAGN, Falque V. (2005). Amide bond formation and peptide coupling. Tetrahedron, 61, 10827–10852.
- Neutra MR, Frey A, Kraehenbuhl JP. (1996). Epithelial M cells: gateways for mucosal infection and immunization. Cell, 86, 345–348.
- Schnurch AB, Humenberger C, Valenta C. (1998). Basic studies on bioadhesive delivery systems for peptide and protein drugs. Int J Pharm, 165, 217–225.
- Shargel L, Yu A. (1999). Applied Biopharmaceutics and Pharmacokinetics, 4th ed., chapter 5, New York,USA: Mc Graw Hill publisher.
- Sugawara S, Imai T, Otagiri M. (1994). The controlled release of prednisolone using alginate gel. Pharm Res, 11, 272–277.
- Tiyaboonchai W. (2003). Chitosan Nanoparticles: A Promising System for Drug Delivery. Naresuan University Journal, 11, 51–66.
- Vila A, Sánchez A, Tobío M, Calvo P, Alonso MJ. (2002). Design of biodegradable particles for protein delivery. J Control Release, 78, 15–24.
- Wang GQ, Cochrane T, McCarron P. (2005). Modulation of surface charge, particle size and morphological properties of chitosan TPP nanoparticles intended for gene delivery. Colloids Surf B, 44, 65–73.
- Wang W. (1999). Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm, 185, 129–188.
- Yotsuyanagi T, Ohkubo T, Ohhashi T, Ikeda K. (1987). Calcium induced gelation of alginic acid and pH-sensitive reswelling of dried gels. Chem Pharm Bull, 35, 1555–1563.